Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostatic Artery Embolization vs Transurethral Resection of the Prostate or Open Prostatectomy in Patients With Symptomatic Benign Prostatic Hyperplasia

NCT04084938 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04084938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostatic Artery Embolization vs Transurethral Resection of the Prostate or Open Prostatectomy in Patients With Symptomatic Benign Prostatic Hyperplasia
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2019
Completion date
December 31, 2027
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia, embolization therapeutic, post-op complication, transurethral resection of prostate syndrome